FENC · Fennec Pharmaceuticals Inc.

Summary

Fennec Pharmaceuticals Inc. filed an 8-K on February 20, 2026, under Item 8.01 with Exhibit 99.1 Press Release attached, which is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. Item 9.01 lists the exhibits including the press release and cover page.

Key takeaways

• Filing date: 2026-02-20
• Form Type: 8-K
• Item 8.01 disclosure with Exhibit 99.1 Press Release
• Exhibit 99.1 not deemed 'filed' under Section 18
• Item 9.01 includes Exhibits 99.1 and 104